Application of Oral Chinese Patent Medicine in Corona Virus Disease-19

WANG Yizhu; LIU Fang; ZHANG Xianglin

doi:10.14009/j.issn.1672-2124.2020.03.001

您当前的位置：

首页 >

文章列表页 >

Application of Oral Chinese Patent Medicine in Corona Virus Disease-19

更新时间：2022-10-08

- Application of Oral Chinese Patent Medicine in Corona Virus Disease-19
- Vol. 20, Issue 3, Pages: 257-261(2020)
- 作者机构：
  
  1. 中日友好医院药学部
  2. 北京中医药大学中药学院
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.03.001
  CLC： R259
- Published：2020，
扫描看全文
[1]王一竹,柳芳,张相林.新型冠状病毒肺炎诊疗方案中的口服中成药应用综述[J].中国医院用药评价与分析,2020,20(03):257-261+267.

WANG Yizhu, LIU Fang, ZHANG Xianglin. Application of Oral Chinese Patent Medicine in Corona Virus Disease-19. [J]. 20(3):257-261(2020)
[1]王一竹,柳芳,张相林.新型冠状病毒肺炎诊疗方案中的口服中成药应用综述[J].中国医院用药评价与分析,2020,20(03):257-261+267. DOI： 10.14009/j.issn.1672-2124.2020.03.001.

WANG Yizhu, LIU Fang, ZHANG Xianglin. Application of Oral Chinese Patent Medicine in Corona Virus Disease-19. [J]. 20(3):257-261(2020) DOI： 10.14009/j.issn.1672-2124.2020.03.001.

摘要

新型冠状病毒肺炎（corona virus disease-19

COVID-19）疫情危害近3个月

中西药治疗方案推荐百家争鸣。国家卫生健康委员会先后发布6版《新型冠状病毒肺炎诊疗方案》

根据医学观察期、临床治疗期、重症期和恢复期4个病情阶段

推荐了中医药治疗方案。中成药是中医治疗方案中的重要组成

藿香正气胶囊（丸、水及口服液）、金花清感颗粒、连花清瘟胶囊和疏风解毒胶囊是医学观察期推荐使用的4种口服中成药

本文就其中医治则、临床研究及用药安全进行文献综述

以期为COVID-19防治中的合理用药提供参考。

Abstract

Corona virus disease-19（ COVID-19） epidemic lasts for nearly 3 months

different Chinese and Western medicine treatment regimens are recommended. The National Health Commission of the People’s Republic of China has issued 6 editions of the COVID-19 Diagnosis and Treatment Program. According to the medical observation period

the clinical treatment period

the severe period and the recovery period

traditional Chinese medicine treatment regimens are recommended. Chinese patent medicine is the important component in the treatment regimen of traditional Chinese medicine. Four kinds of oral Chinese patent medicine are recommended in the medical observation period

including Huoxiang Zhengqi capsules（ pills

liquid and oral liquid）

Jinhua Qinggan granules

Lianhua Qingwen capsules and Shufeng Jiedu capsules. This article reviews the literature related to traditional Chinese medicine treatment

clinical research and medication safety

so as to provide reference for rational drug use in the prevention and treatment of COVID-19.

关键词

诊疗方案COVID-19中成药医学观察期

Keywords

Diagnosis and treatment regimensCOVID-19Chinese patent medicineMedical observation period

references

查看原文

Views

711

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of Clinical Status of Guiding Herbs for Chinese Patent Medicine Included in Chinese Pharmacopoeia （Part Ⅰ）

Review on 6 000 Prescriptions of Chinese Patent Medicine for Digestive System Disease and Analysis on Its Medication Rationality

Systematic Review of Efficacy and Safety of Oral Chinese Patent Medicine in the Treatment of Adult Cough Variant Asthma

Statistical Analysis on Application of Chinese Patent Medicine by Western Clinicians in A General Hospital Based on Information System and Questionnaire Survey

Investigation and Analysis on Cognition for Rational Application of Chinese Patent Medicine Among Different Categories of Medical Personnel

Related Author

杨丽萍

张碧华

邵晖

叶爱军

ZENG Weixin

ZHANG Mo

LIU Min

GU Hongyan

Related Institution

Audit Section, Beijing Xuanwu Traditional Chinese Medicine Hospital

Beijing Hospital

Beijing Key Laboratory of Evaluation on Clinical Rational Drug Application

Dept. of Pharmacy, Beijing Shijitan Hospital Affiliated to Capital Medical University

Dept.of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Guangxi University of Chinese Medicine

⁰